CIP2A Promotes Proliferation of Spermatogonial Progenitor Cells and Spermatogenesis in Mice
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Protein phosphatase 2A (PP2A) is a critical regulator of protein serine/threonine phosphorylation. However, the physiological and developmental roles of different PP2A complexes are very poorly understood. Here, we show that a newly characterized PP2A inhibitory protein CIP2A is co-expressed with ki-67 and with self-renewal protein PLZF in the spermatogonial progenitor cell (SPC) population in the testis. CIP2A and PLZF expression was shown also to correlate Ki-67 expression in human testicular spermatogonia. Functionally, CIP2A mutant mouse testes exhibited smaller number of PLZF-positive SPCs and reduced sperm counts. Moreover, seminiferous tubuli cells isolated from CIP2A mutant mice showed reduced expression of Plzf and other renewal genes Oct-4 and Nanog at mRNA level. However, PLZF-deficient testes did not show altered CIP2A expression. Importantly, spermatogonia-specific restoration of CIP2A expression rescued PLZF expression and sperm production defects observed in CIP2A mutant mice. Taken together, these results reveal first physiological function for an emerging human oncoprotein CIP2A, and provide insights into maintenance of PLZF-positive progenitors. Moreover, demonstration that CIP2A expression can be systematically inhibited without severe consequences to normal mouse development and viability may have clinical relevance regarding targeting of oncogenic CIP2A for future cancer therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“without lack of any detrimental normal tissue homeostasis effects in a CIP2A-deficient mouse model [11,22,23]”
From Oncoprotein CIP2A is stabilized via interaction with tumor suppressor PP2A/B56 (2017) · cites this paper as [23]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“it does not compromise normal mouse development or growth, except for a defect in spermatogenesis [11,22,23]”
From Oncoprotein CIP2A is stabilized via interaction with tumor suppressor PP2A/B56 (2017) · cites this paper as [23]
In the citing paper
“Interestingly, a spermatogenesis defect was also one of only two phenotypes that could be found in a constitutive KO mouse model for CIP2A (Cancerous Inhibitor of PP2A) [30].”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [30]
In the citing paper
“CIP2A has a restricted expression profile in most human and mouse normal tissues (5,6)”
From Ovarian cancers with low CIP2A tumor expression constitute an APR-246 sensitive disease subtype (2021) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Essential role of Plzf in maintenance of spermatogonial stem cells
Costoya, J. A., Hobbs, R. M., Barna, M., Cattoretti, G., Manova, K., Sukhwani, M., Orwig, K. E., Wolgemuth, D. J., & Pandolfi, P. P. (2004) · Nature Genetics · doi:10.1038/ng1367 · Cited by 952 · cited 4×
“Stage-dependent mRNA expression patterns of endogenous CIP2A and spermatogonial markers Plzf and Stra8, which are markers of spermatogonia self-renewal and differentiation, were examined (Buaas et al., 2004; Costoya et al., 2004; Zhou et al., 2008).”
BackgroundInfluentialSelf-citationPlzf is required in adult male germ cells for stem cell self-renewal
Buaas, F. W., Kirsh, A. L., Sharma, M., McLean, D. J., Morris, J. L., Griswold, M. D., de Rooij, D. G., & Braun, R. E. (2004) · Nature Genetics · doi:10.1038/ng1366 · Cited by 890 · cited 4×
“Stage-dependent mRNA expression patterns of endogenous CIP2A and spermatogonial markers Plzf and Stra8, which are markers of spermatogonia self-renewal and differentiation, were examined (Buaas et al., 2004; Costoya et al., 2004; Zhou et al., 2008).”
BackgroundInfluentialCIP2A inhibits PP2A in human malignancies
Junttila, M. R., Puustinen, P., Niemelä, M., Ahola, R., Arnold, H., Böttzauw, T., Ala-aho, R., Nielsen, C., Ivaska, J., Taya, Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.044 · Cited by 677 · cited 5×
“CIP2A-specific siRNA [8] effectively inhibited CIP2A mRNA”
BackgroundMethodInfluentialSelf-citationRegulation of Spermatogonial Stem Cell Self-Renewal in Mammals
Oatley, J. M., & Brinster, R. L. (2008) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.24.110707.175355 · Cited by 550 · cited 1×
“In testicular seminiferous tubules, the only actively proliferating and self-renewing cell types are the spermatogonial stem and progenitor cells (SPCs) that reside in the basal layer of the tubules [1].”
BackgroundProtein phosphatase 2A regulatory subunits and cancer
Eichhorn, P. J. A., Creyghton, M. P., & Bernards, R. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.05.005 · Cited by 513 · cited 1×
“Protein phosphatase 2A (PP2A) is a crucial regulator of cellular serine/threonine phosphorylation [6,7].”
BackgroundFunctional Hierarchy and Reversibility Within the Murine Spermatogenic Stem Cell Compartment
Nakagawa, T., Sharma, M., Nabeshima, Y.-I., Braun, R. E., & Yoshida, S. (2010) · Science · doi:10.1126/science.1182868 · Cited by 472 · cited 1×
“Therefore, identifying the mechanisms that regulate proliferation and self-renewal of this cell type has been of great interest lately [2,5,17,18].”
BackgroundGeneration of functional multipotent adult stem cells from GPR125+ germline progenitors
Seandel, M., James, D., Shmelkov, S. V., Falciatori, I., Kim, J., Chavala, S., Scherr, D. S., Zhang, F., Torres, R., Gale, N. W., et al. (2007) · Nature · doi:10.1038/nature06129 · Cited by 452 · cited 1×
“Importantly, while self-renewal markers were down regulated in CIP2A samples, spermatogonial expression of Gpr125, that is not linked with self-renewal [14], or Stra8, a marker of spermatogonia differentiation [15], was instead increased in CIP2A mice (Figure 4A).”
BackgroundSelf-citationMultiple pathways regulated by the tumor suppressor PP2A in transformation
Westermarck, J., & Hahn, W. C. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.02.001 · Cited by 344 · cited 1×
“Protein phosphatase 2A (PP2A) is a crucial regulator of cellular serine/threonine phosphorylation [6,7].”
BackgroundSelf-citationPlzf Regulates Germline Progenitor Self-Renewal by Opposing mTORC1
Hobbs, R. M., Seandel, M., Falciatori, I., Rafii, S., & Pandolfi, P. P. (2010) · Cell · doi:10.1016/j.cell.2010.06.041 · Cited by 273 · cited 4×
“Therefore, identifying the mechanisms that regulate proliferation and self-renewal of this cell type has been of great interest lately [2,5,17,18].”
BackgroundResultInfluentialSelf-citationMouse Germ Line Stem Cells Undergo Rapid and Stochastic Turnover
Klein, A. M., Nakagawa, T., Ichikawa, R., Yoshida, S., & Simons, B. D. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.05.017 · Cited by 247 · cited 1×
“Therefore, identifying the mechanisms that regulate proliferation and self-renewal of this cell type has been of great interest lately [2,5,17,18].”
Background
Cited by
Khanna, A., Pimanda, J. E., & Westermarck, J. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1994 · Cited by 154
“In contrast to testicular progenitors and various tumor cells, CIP2A expression is relatively low in most normal human and mouse tissues (4, 19), which may also explain the viability of CIP2A mutant mice.”
BackgroundSelf-citationLaine, A., Sihto, H., Come, C., Rosenfeldt, M. T., Zwolinska, A., Niemelä, M., Khanna, A., Chan, E. K., Kähäri, V.-M., Kellokumpu-Lehtinen, P.-L., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0292 · Cited by 130
“CIP2A Inactivation Induces Senescence and Growth Arrest and Restricts Tumorigenesis in a Breast Cancer Mouse Model We have recently generated a CIP2A hypomorphic mouse model (CIP2AHOZ) using gene trap technology (44).”
MethodSelf-citationPhysiologic functions of PP2A: Lessons from genetically modified mice
Reynhout, S., & Janssens, V. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.07.010 · Cited by 124
Adam, S., Rossi, S. E., Moatti, N., De Marco Zompit, M., Xue, Y., Ng, T. F., Álvarez-Quilón, A., Desjardins, J., Bhaskaran, V., Martino, G., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00266-w · Cited by 121
Non-genomic mechanisms of protein phosphatase 2A (PP2A) regulation in cancer
Kauko, O., & Westermarck, J. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.01.005 · Cited by 111
Self-citationVainonen, J. P., Momeny, M., & Westermarck, J. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abe2967 · Cited by 104
Self-citationOncoprotein CIP2A is stabilized via interaction with tumor suppressor PP2A/B56
Wang, J., Okkeri, J., Pavic, K., Wang, Z., Kauko, O., Halonen, T., Sarek, G., Ojala, P. M., Rao, Z., Xu, W., et al. (2017) · The EMBO Reports · doi:10.15252/embr.201642788 · Cited by 95
“Impact of CIP2A on both oncogenic RAS signaling [10,13,36] and MYC activity in vivo [10,12,22], without lack of any detrimental normal tissue homeostasis effects in a CIP2A-deficient mouse model [11,22,23], further illustrated the potential of CIP2A as a future cancer therapy target.”
Self-citationThe basic biology of PP2A in hematologic cells and malignancies
Haesen, D., Sents, W., Lemaire, K., Hoorne, Y., & Janssens, V. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00347 · Cited by 73
“CIP2A knockout mice show no overt phenotypes, except for a defect in spermatogenesis (91).”
BackgroundThe role of CIP2A in cancer: A review and update
Soofiyani, S. R., Hejazi, M. S., & Baradaran, B. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.08.146 · Cited by 72
De, P., Carlson, J., Leyland-Jones, B., & Dey, N. (2014) · Oncotarget · doi:10.18632/oncotarget.2127 · Cited by 73
“, revealed first physiological function for oncoprotein CIP2A [121].”
Myant, K., Qiao, X., Halonen, T., Come, C., Laine, A., Janghorban, M., Partanen, J. I., Cassidy, J., Ogg, E.-L., Cammareri, P., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.003 · Cited by 59
“…pS62MYC Expression and MYC-Mediated Proliferation Induction Next we studied the relevance of CIP2A for mitogen-induced MYC regulation in mouse embryonic fibroblasts (MEFs) isolated from CIP2A-deficient (CIP2AHOZ) mice (Laine et al., 2013; Ventelä et al., 2012) and their wild-type counterparts.”
BackgroundMethodInfluentialSelf-citationVentelä, S., Sittig, E., Mannermaa, L., Mäkelä, J., Kulmala, J. A. J., Löyttyniemi, E., Strauss, L., Carpén, O., Toppari, J., Grenman, R. A., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2670 · Cited by 66
“1C), whereas the spermatogonial markers Plzf and CD9 showed a strong increase at 96 and 144 hours after irradiation, coinciding with increased proliferation and repopulation of the spermatogonia.”
BackgroundResultInfluentialSelf-citationClinical significance of cancerous inhibitor of protein phosphatase 2A in human cancers
Khanna, A., & Pimanda, J. E. (2016) · International Journal of Cancer · doi:10.1002/ijc.29431 · Cited by 57
“Saliently, the CIP2A knockout-mouse has been shown to have a benign phenotype.(24) Taken together, these findings make targeting CIP2A an effective alternative therapeutic strategy for MYC– driven malignancies.”
BackgroundZhao, Q., Zhao, M., Parris, A. B., Xing, Y., & Yang, X. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3588 · Cited by 56
“It acts as an endogenous inhibitor of PP2A and has a broad impact on cellular proliferation and survival (12,39-41).”
BackgroundLaine, A., Nagelli, S. G., Farrington, C., Butt, U., Cvrljevic, A. N., Vainonen, J. P., Feringa, F. M., Grönroos, T. J., Gautam, P., Khan, S., et al. (2020) · doi:10.1101/2020.08.27.269902 · Cited by 54
“CIP2A western blots from 538 MDA-MB-468 (D) and patient-derived stem cell-like cells (14-72)(E) on treatment with indicated SMAPs for 539 24h.”
MethodSelf-citationChk1 Targeting Reactivates PP2A Tumor Suppressor Activity in Cancer Cells
Khanna, A., Kauko, O., Böckelman, C., Laine, A., Schreck, I., Partanen, J. I., Szwajda, A., Bormann, S., Bilgen, T., Helenius, M., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1002 · Cited by 46
“Moreover, hypomorphic CIP2A mouse model (11) shows impaired MMTV-neu-driven mammary tumor development and progression (7).”
Self-citationKerosuo, L., Neppala, P., Hsin, J., Mohlin, S., Vieceli, F. M., Török, Z., Laine, A., Westermarck, J. K., & Bronner-Fraser, M. E. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800039115 · Cited by 51
“Like MycN, CIP2A (cancerous inhibitor of protein phosphatase 2A) is overexpressed in several cancer types (30–34) and has been shown to play a role during CNS development as well as in the testis (35, 36).”
BackgroundSelf-citationProtein Phosphatase 2A (PP2A) mutations in brain function, development, and neurologic disease
Verbinnen, I., Vaneynde, P., Reynhout, S., Lenaerts, L., Derua, R., Houge, G., & Janssens, V. (2021) · Biochemical Society Transactions · doi:10.1042/bst20201313 · Cited by 56
Characterization of GFR α‐1‐Positive and GFR α‐1‐Negative Spermatogonia in Neonatal Pig Testis
Lee, K. H., Lee, W., Kim, J., Yoon, M., Kim, N., Kim, J., Uhm, S. J., Kim, D., Chung, H., & Song, H. (2013) · Reproduction in Domestic Animals · doi:10.1111/rda.12193 · Cited by 42
Ethoxysanguinarine Induces Inhibitory Effects and Downregulates CIP2A in Lung Cancer Cells
Liu, Z., Ma, L., Wen, Z.-S., Cheng, Y.-X., & Zhou, G.-B. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400341k · Cited by 40
Kim, M.-O., Choe, M. H., Yoon, Y. N., Ahn, J., Yoo, M., Jung, K., An, S., Hwang, S., Oh, J. S., & Kim, J. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.08.009 · Cited by 40
Jeong, A. L., Lee, S., Park, J. S., Han, S., Jang, C.-Y., Lim, J.-S., Lee, M. S., & Yang, Y. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.507954 · Cited by 35
“Moreover, CIP2A is strongly expressed in testes and promotes the proliferation of spermatogonial progenitor cells and spermatogenesis (66).”
BackgroundMäkelä, J., Toppari, J., Rivero‐Müller, A., & Ventelä, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090088 · Cited by 35
Self-citationPallai, R., Bhaskar, A., Barnett-Bernodat, N., Ebert, C., Pusey, M., Nickels, J. T., & Rice, L. M. (2015) · Tumor Biology · doi:10.1007/s13277-015-3326-1 · Cited by 26
“hypomorphic models [53] and null animals (L.”
CIP2A coordinates phosphosignaling, mitosis, and the DNA damage response
Nagelli, S. G., & Westermarck, J. K. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.09.001 · Cited by 26
Self-citationCIP2A promotes T-cell activation and immune response to Listeria monocytogenes infection
Côme, C., Cvrljevic, A., Khan, M. M., Treise, I., Adler, T., Aguilar-Pimentel, J. A., Au-Yeung, B., Sittig, E., Laajala, T. D., Chen, Y., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152996 · Cited by 20
“Comparison of CIP2A mRNA expression between different mouse tissues shows the highest level of expression in testis (Fig 1A) [4, 12].”
BackgroundMethodInfluentialSelf-citationDepletion of SMC5/6 sensitizes male germ cells to DNA damage
Hwang, G. H., Verver, D. E., Handel, M. A., Hamer, G., & Jordan, P. W. (2018) · Molecular Biology of the Cell · doi:10.1091/mbc.e18-07-0459 · Cited by 20
Khanna, A., Thoms, J. A. I., Stringer, B. W., Chung, S. A., Ensbey, K. S., Jue, T. R., Jahan, Z., Subramanian, S., Anande, G., Shen, H. M., et al. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0934 · Cited by 22
“CIP2A loss is well tolerated (46) and we believe that targeting CIP2A and thereby indirectly depleting pSTAT3 in high-CIP2A–expressing cells is a superior alternative to direct targeting of STAT3 and will limit unwarranted toxicity to healthy tissues.”
BackgroundMäkelä, E., Pavic, K., Varila, T., Salmenniemi, U., Löyttyniemi, E., Nagelli, S. G., Ammunét, T., Kähäri, V.-M., Clark, R. E., Elo, L. L., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3679 · Cited by 18
Self-citationKnockdown of CIP2A sensitizes ovarian cancer cells to cisplatin: an in vitro study.
Zhang, X., Xu, B., Sun, C., Wang, L., & Miao, X. (2015) · PubMed Central · Cited by 20
CIP2A Constrains Th17 Differentiation by Modulating STAT3 Signaling
Khan, M. M., Ullah, U., Khan, M. H., Kong, L., Moulder, R., Välikangas, T., Bhosale, S. D., Komsi, E., Rasool, O., Chen, Z. J., et al. (2020) · iScience · doi:10.1016/j.isci.2020.100947 · Cited by 21
Self-citationProtein phosphatase 2A (PP2A) inhibitor CIP2A indicates resistance to radiotherapy in rectal cancer
Birkman, E., Elzagheid, A. I., Jokilehto, T., Avoranta, T., Korkeila, E. A., Kulmala, J. A. J., Syrjänen, K. J., Westermarck, J. K., & Sundström, J. T. T. (2018) · Cancer Medicine · doi:10.1002/cam4.1361 · Cited by 20
“In normal tissues, except testis, CIP2A is expressed only at a low level, and its inhibition does not impair normal development or viability in mice [19, 28].”
BackgroundSelf-citationTian, Y., Chen, H., Qiao, L., Zhang, W., Zheng, J., Zhao, W., Chen, J. J., & Zhang, W. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13693 · Cited by 19
“In addition, CIP2A mutant mouse models showed no obvious abnormality in mouse development and viability.(43) Therefore, the expression specificity and limited toxicity indicate that CIP2A inhibitors may be a hopeful therapeutic strategy for treatment of cervical cancer.”
Tarek, M., Yahia, A., Elnakib, M., & ElHefnawi, M. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104986 · Cited by 16
Tian, J., Xu, H., Zhang, Y., Shi, X., Wang, W., Gao, H., & Bi, Y. (2019) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2019.109579 · Cited by 12
Routila, J., Bilgen, T., Saramäki, O. R., Grenman, R. A., Visakorpi, T., Westermarck, J. K., & Ventelä, S. (2015) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12372 · Cited by 15
Self-citationRoutila, J., Mäkelä, J., Luukkaa, H., Leivo, I. V. V., Irjala, H., Westermarck, J. K., Mäkitie, A. A., & Ventelä, S. (2015) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22312 · Cited by 11
“Based on the above findings and our previous experience on working with PP2A (Ventel€a et al., 2012; Khanna et al., 2013) we further focused on characterization of PP2A status in salivary gland tumors.”
ResultSelf-citationYang, C., Chou, I., Cho, D., Lin, C., Huang, H., Ho, Y.-C., Liu, T., Li, Y.-H., & Chang, J. (2018) · Neurogenetics · doi:10.1007/s10048-018-0548-6 · Cited by 9
Rules for PP2A-controlled phosphosignalling and drug responsesPreprint
Kauko, O., Imanishi, S. Y., Kulesskiy, E., Laajala, T. D., Yetukuri, L., Laine, A., Jumppanen, M., Haapaniemi, P., Ruan, L., Yadav, B., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/271841 · Cited by 11
Self-citationChen, X., Tang, S.-X., Zhang, J.-H., Zhang, L., & Wang, Y.-W. (2017) · Oncology Reports · doi:10.3892/or.2017.5759 · Cited by 8
RetractedFlurochloridone induced abnormal spermatogenesis by damaging testicular Sertoli cells in mice
Sun, W., Tian, F., Pan, H., Chang, X., Xia, M., Hu, J., Wang, Y., Li, R., Li, W., Yang, M., et al. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.114163 · Cited by 8
Hu, W., Liuyang, Z., Tian, Y., Liang, J., Zhang, X., Zhang, H., Wang, G., Huo, Y., Shentu, Y., Wang, J., et al. (2022) · EMBO Reports · doi:10.15252/embr.202254911 · Cited by 8
Self-citationOvarian Cancers with Low CIP2A Tumor Expression Constitute an APR-246–Sensitive Disease Subtype
Cvrljevic, A. N., Butt, U., Huhtinen, K., Grönroos, T. J., Böckelman, C., Lassus, H., Butzow, R., Haglund, C., Kaipio, K., Arsiola, T., et al. (2022) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-21-0622 · Cited by 5
Self-citationOvarian cancers with low CIP2A tumor expression constitute an APR-246 sensitive disease subtype
Cvrljevic, A. N., Butt, U., Huhtinen, K., Grönroos, T. J., Böckelman, C., Lassus, H., Kaipio, K., Arsiola, T., Laajala, T. D., Connolly, D. C., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.31.437804 · Cited by 5
Self-citationLiu, Z., Xi, Q., Hou, M., Zou, T., Liu, H., Zhou, X., Jin, L., Zhu, L., & Zhang, X. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167228 · Cited by 5
Ventelä, S., Mäkelä, J., Sears, R. C., Toppari, J., & Westermarck, J. K. (2016) · Matters · doi:10.19185/matters.201602000040 · Cited by 7
“Based on (a) expression and functional role of CIP2A in spermatogonia (Ventel _2012[3]), (b) the established functional link between CIP2A and MYC (Myant 2015[2]), and (c) the role of both CIP2A and MYC in regulating progenitor cell fate (Ventel _2012[3])(Myant 2015[2])(Wilkins 2008[4]), we assessed the status of MYC…”
BackgroundSelf-citationXu, Z., Chen, X., Hegazy, A. M., Zhang, S., Liu, X., Tian, J., Wu, J., Shi, F., Li, L., Niu, X., et al. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.04.009 · Cited by 4
Protein phosphatase 2A (PP2A) function in male germ cells and its importance for male fertility
Simon, V. (2025) · Endocrine Connections · doi:10.1530/ec-25-0554 · Cited by 1
“Surprisingly, CIP2A, the other endogenous inhibitor of PP2A-B56, was not detected in the single-cell RNA-seq dataset from Wang et al. (67).”
InfluentialTargeting BRCA-mutated tumors in mitosis
Menolfi, D., & Zha, S. (2021) · Nature Cancer · doi:10.1038/s43018-021-00293-7 · Cited by 1
Routila, J., & Westermarck, J. K. (2015) · Journal of Molecular Biomarkers & Diagnosis · doi:10.4172/2155-9929.s2-014
“Importantly, despite a spermatogenesis defect, CIP2A is dispensable for normal mouse growth and development and the adult mice do not show any apparent pathology [19,20].”
BackgroundSelf-citationIdentification and characterization of new genes and pathways regulating spermatogonial cell fate
Mäkelä, J. (2012) · UTUPub (University of Turku)
Self-citationNovel PP2A biomarkers in cancer
Mäkelä, E. (2021) · UTUPub (University of Turku)
Laine, A., Nagelli, S. G., Farrington, C. C., Butt, U., Cvrljevic, A. N., Vainonen, J. P., Feringa, F. M., Grönroos, T. J., Gautam, P., Khan, S., et al. (2023) · doi:10.1158/0008-5472.22428462
Self-citationLaine, A., Nagelli, S. G., Farrington, C. C., Butt, U., Cvrljevic, A. N., Vainonen, J. P., Feringa, F. M., Grönroos, T. J., Gautam, P., Khan, S., et al. (2023) · doi:10.1158/0008-5472.22428462.v1
Self-citationCvrljevic, A. N., Butt, U., Huhtinen, K., Grönroos, T. J., Böckelman, C., Lassus, H. J., Bützow, R. C., Haglund, C. H., Kaipio, K., Arsiola, T., et al. (2023) · doi:10.1158/1535-7163.c.6543912
Self-citationThe Emerging Role of the Cancerous Inhibitor of Protein Phosphatase 2A in Pulmonary Diseases
Hamza, H., Nirmal, D., Pappas, S., Ebubechukwu, U. J., Gill, S., Al-Ajam, A., Ohlmeyer, M. H. J., & Geraghty, P. M. (2025) · Medicina · doi:10.3390/medicina61101740
“In non-cancerous cells, CIP2A has relatively low gene expression throughout the body, except in sperm cells [35], intestinal stem cells [73], and some populations of T cells [68].”
InfluentialOhmori, K. (2025) · Biomolecules · doi:10.3390/biom15101431
“Furthermore, CIP2A contributes to tumor progression by promoting cell proliferation, survival, self-renewal, and resistance to senescence and apoptosis, partly through MEK-mediated activation of ERK signaling [161].”
Validation of potential CIP2A inhibitors based on computer modeling in triple-negative breast cancer
Lehtinen, A. (2021) · UTUPub (University of Turku)
CIP2A is a critical DNA damage response protein that drives basal-like breast cancer
Nagelli, S. G. (2023) · UTUPub (University of Turku)
Haesen, D. (2016) · Lirias
Takemoto, K., Girardini, K. N., Boria, A., Rosado, J., Konakanchi, T., Vachhani, S., Springer, S. M., & Kanadia, R. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag159
“F and Table S2 ) [ 67 –69 ].”
Metadata
- Authors
- Ventelä, S., Côme, C., Mäkelä, J.-A., Hobbs, R. M., Mannermaa, L., Kallajoki, M., Chan, E. K., Pandolfi, P. P., Toppari, J., & Westermarck, J.
- Affiliations
- Åbo Akademi University (FI)
- University of Turku (FI)
- Beth Israel Deaconess Medical Center (US)
- University of Florida (US)
- Corresponding author
- Westermarck, Jukka
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-03-26
- Volume
- 7
- Issue
- 3
- Pages
- e33209
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3312892
- OpenAlex
- W2073664416
- Cited by
- 58
- References
- 23
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 4 · 2022: 3 · 2021: 9 · 2020: 2 · 2019: 1 · 2018: 8 · 2017: 4 · 2016: 3 · 2015: 8 · 2014: 4 · 2013: 7 · 2012: 1
- FWCI
- 7.45
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Academy of Finland
- National Institutes of Health (UL1TR000064)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Keywords
- CIP2A, protein phosphatase 2A, spermatogenesis, PLZF, self-renewal, Ki-67, Oct4, Nanog, testis, sperm count, oncoprotein, cancer therapy targets
- MeSH terms
- Promyelocytic Leukemia Zinc Finger Protein, Animals, Autoantigens, Female, Humans, Immunohistochemistry, Male, Membrane Proteins, Mice, Inbred C57BL, Spermatogenesis, Spermatogonia, Stem Cells, Time Factors, Mice, Knockout, Gene Expression Regulation, Developmental, Reverse Transcriptase Polymerase Chain Reaction, RNA Interference, Cell Proliferation, Mice, Kruppel-Like Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.